Blood pressure, smoking and oral contraceptive control after cryptogenic stroke in young adults in the PFO-ASA study

Cerebrovascular Diseases

Volumn 20, Issue 1, 2005, Pages 41-45

  Arquizan, Caroline ^a   Touzé, Emmanuel ^a   Moulin, Thierry ^b   Woimant, France ^c   Ducrocq, Xavier ^d   Mas, Jean Louis ^a  

^a CENTRE HOSPITALIER SAINTE ANNE   (France)

^b UNIVERSITY HOSPITAL OF BESANÇON   (France)

^c HÔPITAL LARIBOISIÈRE   (France)

^d UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

Blood pressure; Oral contraception; Smoking

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ADULT; AGE DISTRIBUTION; ALCOHOL CONSUMPTION; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MEDICAL RECORD; MULTICENTER STUDY; ORAL CONTRACEPTION; PATIENT INFORMATION; PRIORITY JOURNAL; RANKIN SCALE; RISK FACTOR; SEX DIFFERENCE; SMOKING; SMOKING HABIT; STROKE; SYSTOLIC BLOOD PRESSURE;

BLOOD PRESSURE; BODY MASS INDEX; CEREBROVASCULAR ACCIDENT; CONTRACEPTIVES, ORAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; MALE; RECURRENCE; RISK FACTORS; SMOKING;

EID: 22344453010     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000086203     Document Type: Article

References (11)

1. Mouradian MS, Majumdar SR, Senthilselvan A, Khan K, Shuaib A: How well are hypertension, hyperlipidemia, diabetes, and smoking managed after a stroke or transient ischemic attack? Stroke 2002;33:1656-1659.
2. Bak S, Sindrap SH, Alslev T, Kristensen O, Christensen K, Gaist D: Cessation of smoking after first-ever stroke. A follow-up study. Stroke 2002;333:2263-2269.
3. Redfern J, McKevitt C, Dundas R, Rudd AG, Wolfe CDA: Behavioral risk factor prevalence and lifestyle change after stroke. A prospective study. Stroke 2000;31:1877-1881.
4. Kernan WN, Viscoli CM, Brass LM, Makuch RW, Sarrel PM, Horwitz RI: Blood pressure exceeding national guidelines among women after stroke. Stroke 2000;31:415-419.
5. Joseph LN, Babikian VL, Allen NC, Winter MR: Risk factor modification in stroke prevention. The experience of a stroke clinic. Stroke 1999;30:16-20.
6. Mas JL, Arquizan C, Lamy C, Zuber M, Cabanes L, Derumeaux G, Coste J, for the Patent Foramen Ovale and Atrial Septal Aneurysm Study Group: Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med 2001;345:1740-1746.
7. Headache Classification Committee of the International Headache Society: Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988;8:19-28.
8. Van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJA, Van Gijn J: Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1988;19:604-607.
9. Wolf PA, Clagett GP, Easton JD, Goldstein LB, Gorelick PB, Kelly-Hayes M, Sacco RL, Whisnant JP: Preventing ischemic stroke in patients with prior stroke and transient ischemic attack. A statement for healthcare professionals from the Stroke Council of the American Heart Association. Stroke 1999;30:1991-1994.
10. Leys D, Bandu L, Hénon H, Lucas C, Mounier-Vehier F, Rondepierre P, Godefroy O: Clinical outcome in 287 consecutive young adults (15-45 years) with ischemic stroke. Neurology 2002;59:26-33.
11. Sappok T, Faulstich A, Stuckert E, Kruck H, Marx P, Koennecke HC: Compliance with secondary prevention of ischemic stroke. A prospective evaluation. Stroke 2001;32:1884-1889.